K. Brand et al., DYSREGULATION OF MONOCYTIC NUCLEAR FACTOR-KAPPA-B BY OXIDIZED LOW-DENSITY-LIPOPROTEIN, Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 1901-1909
Nuclear factor-kappa B (NF-kappa B)/Rel transcription factors may be i
nvolved in atherosclerosis, as is suggested by the presence of activat
ed NF-kappa B in human atherosclerotic lesions. The aim of the present
study was to investigate the effects of oxidized LDL (oxLDL) on the N
F-kappa B system in human THP-1 monocytic cells as well as adherent mo
nocytes. Our results demonstrate that short-term incubation of these c
ells with oxLDL activated p50/p65 containing NF-kappa B dimers and ind
uced the expression of the target gene IL-8. This activation of NF-kap
pa B was inhibited by the antioxidant and H2O2 scavenger pyrrolidine d
ithiocarbamate and the proteasome inhibitor PSI. The oxLDL-induced NF-
kappa B activation was accompanied by an initial depletion of I kappa
B-alpha followed by a slight transient increase in the level of this i
nhibitor protein. In contrast, long-term treatment with oxLDL prevente
d the lipopolysaccharide-induced depletion of I kappa B-alpha, accompa
nied by an inhibition of both NF-kappa B activation and the expression
of tumor necrosis factor-alpha and interleukin-1 beta genes. These ob
servations provide additional evidence that oxLDL is a potent modulato
r of gene expression and suggest that (dys)regulation of NF-kappa B/Re
l is likely to play an important role in atherogenesis.